Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on October 14, 2025
Personalized Medicine Bioinformatics Market to Reach $6.39 Billion by 2029 with 13.4% CAGR
The Business Research Company’s Personalized Medicine Bioinformatics Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Get 20% Off All Global …
Personalized Ophthalmology Therapies Global Market Report 2025| Growth, Key Drivers, and Future Trends through 2029
The Business Research Company’s Personalized Ophthalmology Therapies Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Get 20% Off All Global …
Pharmaceutical Digital Platform Market to Reach $21.23 Billion by 2029 with 27.5% CAGR
The Business Research Company’s Pharmaceutical Digital Platform Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Get 20% Off All Global Market …
Demand for Smart Controller For Personal Care And Health Market is forecasted to reach a value of US $4.15 Bn by 2029
The Business Research Company’s Smart Controller For Personal Care And Health Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Get 20% Off All …
Smart Precision Medicine Software Market Expanding With $6.55 Billion at 17.7% CAGR by 2029
The Business Research Company’s Smart Precision Medicine Software Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Get 20% Off All Global Market …
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market to Expand at a 18.3% CAGR by 2029, Reaching US $4.25 Bn
The Business Research Company's Ophthalmic Artificial Intelligence-Assisted Diagnosis Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All …
Organoid Kit Market Forecasted to Achieve US $2.37 Billion by 2029
The Business Research Company's Organoid Kit Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market Reports With Code …
Orphan Drugs Service Market to Reach US $80.62 Billion by 2029
The Business Research Company's Orphan Drugs Service Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market Reports …
Orthotic Gel Insole Market is Projected to Increase at a CAGR of 9% Through 2025-2029
The Business Research Company's Orthotic Gel Insole Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market Reports With …
PD-L1 And PIK3CA Testing Market is Forecasted to Reach a Value of US $2.95 Billion by 2029
The Business Research Company's PD-L1 And PIK3CA Testing Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market Reports …
Percutaneous Puncture Surgery Robot Market Projected to Witness a Growth of US $3.15 Billion by 2029
The Business Research Company's Percutaneous Puncture Surgery Robot Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global …
Period Pain Relief Device Market Projected to Reach $1.59 Billion with 9.7% CAGR by 2029
The Business Research Company's Period Pain Relief Device Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market …
Small Molecule Targeted Cancer Therapy Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights
The Business Research Company's Small Molecule Targeted Cancer Therapy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global …
Small Molecule Targeted Therapy Market Set to Reach $110.52 Billion by 2029
The Business Research Company's Small Molecule Targeted Therapy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market …
Red-Light Therapy Panel Market CAGR to be at 15.3% from 2025 to 2029 | $1.69 Billion Industry Revenue by 2029
The Business Research Company's Red-Light Therapy Panel Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- What Is The Projected Market Size …
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, …
Apollomics, Inc. Company Operational Continuity Update
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), today announced the following company operational update. Apollomics is a clinical-stage biotechnology company advancing innovative …
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic …